Anaphylaxis
Onset: ≤4 hours
Most parents don't know what's planned at their child's next well-visit. Learn how to prepare →
MMR
Measles, Mumps, Rubella
Licensed Brands
- MMR-II FDA approved: 1978
- PRIORIX FDA approved: 2022
- ProQuad (freezer) FDA approved: 2005
- ProQuad (refrigerator-stable) FDA approved: 2005
Included In Well Visit Guides
These are the child-age visit guides where this vaccine is included.
Current U.S. Vaccine Injury Table
SIRVA
Onset: ≤48 hours
Vaccine-strain measles viral disease in an immunodeficient recipient (strain testing not done or inconclusive)
Onset: ≤12 months
Vasovagal syncope
Onset: ≤1 hour
Encephalitis
Onset: 5–15 days
Encephalopathy
Onset: 5–15 days
Chronic arthritis (rubella-containing vaccines)
Onset: 7–42 days
Thrombocytopenic purpura
Onset: 7–30 days
Vaccine-strain measles viral disease in an immunodeficient recipient (vaccine-strain virus identified)
Onset: No onset limit
Compare These Options Clearly
These vaccines target the same disease — but they’re not identical.
- See how reactions differ across brands
- Compare ingredients side-by-side
- Understand what changes — and what doesn’t
Was this topic helpful?